bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.10.16.759688

TiSAM: fusing spatial and histopathology foundation models for whole-slide image segmentation

Abstract

Semantic segmentation of whole-slide images (WSIs) quantifies tissue composition and architecture, but existing models require extensive annotation and lose accuracy as the number of tissue classes increases or on heterogeneous, cross-scanner datasets. Here, we present the Tissue Segment Anything Model (TiSAM), which fuses SAM3 spatial features with UNI2-h pathology features within a multi-scale decoder. Because public benchmarks contain few tissue classes, we release MegaMouse, comprising 36,833 annotations of 52 tissue classes from 12 mouse organs, and an 11-class human pancreas dataset. TiSAM achieved the highest overall performance across four public datasets compared to existing convolutional neural network and vision transformer models, maintained high accuracy on MegaMouse, and maintained high accuracy in the human pancreas dataset when trained on as few as 5 annotated WSIs where previous integrations of SAM with pathology foundation models did not. TiSAM segmentations were also more consistent across eight slide scanners compared to other models. These results establish TiSAM as a general and highly adaptable framework for tissue segmentation, enabling studies containing many tissue classes, limited annotations, or images from multiple scanners.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ding, Z., Dequiedt, L., Forjaz, M., Matos-Romero, V., Shen, Y., Benducci, T., Forjaz, A., Fei, X., Zhu, Y., Nwoga, P., Dhana, W., Pascalin, J., Lee, S. S., Garza, L., Lee, S. H., Pierce, E. J., Canto, M. I., Morton, J. P., Cihakova, D., Wirtz, D., Data Science TeamLab,, Kiemen, A. L.. 2026-10-19. TiSAM: fusing spatial and histopathology foundation models for whole-slide image segmentation. https://doi.org/10.64898/2026.10.16.759688

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

MINT Block: multivariate integration across independent studies to identify multi-omics signatures

Integrative multi-omics analyses can identify molecular signatures spanning multiple layers of a biological system. However, signatures derived from datasets with small sample sizes may not generalise. Combining data from multiple independent studies can increase the available sample size, but may also introduce unwanted variation arising from study-specific differences. Existing approaches typically address this variation sequentially by correcting the data before downstream model fitting, which can inadvertently distort the biological signals of interest. We introduce MINT Block, a framework that integrates multi-omics data across independent studies while simultaneously accounting for study-specific unwanted variation. MINT Block supports multivariate regression and classification analyses, enabling the identification of generalisable multi-omics signatures that capture relationships between different types of molecules and predict sample phenotypes. We evaluated MINT Block using bulk and single-cell multi-omics datasets from studies of human disease and marine biology. Across these applications, we showed that MINT Block identified stable, interpretable molecular signatures and improves prediction accuracy compared with existing sequential approaches.

bioinformatics↗

ChEBI-N - Enrichment Analysis with the ChEBI Ontology

Introduction: Biological and chemical ontologies are structured representations that can be used to map entities such as metabolites onto broader chemical and biological categories. Enrichment analysis applied to such ontologies identifies classes whose representation within a set deviates from an expected background distribution, helping to interpret complex metabolomics measurements. Objectives: This study aimed to develop a tool for ChEBI (Chemical Entities of Biological Interest) ontology-based enrichment analysis, named ChEBI-N (ChEBI eNrichment). It is a successor of the previous tool BiNChE, with new features that broaden its applicability. Methods: We reimplemented BiNChE and extended it to accept SMILES or InChI strings as well as ChEBI IDs. These broaden applicability to datasets with entities that are not yet present in ChEBI. We also constructed organism-specific background populations. Results: We demonstrate the tool on three published metabolomics datasets covering wine, cheese, and human plasma samples. ChEBI-N correctly highlighted relevant enriched classes in all three datasets, such as flavonoids in the wine dataset and fatty acid classes in the cheese dataset. Comparing organism-specific and full-ChEBI backgrounds shows that restricted backgrounds reduce the inflated significance of generic classes, although the most enriched classes remain largely consistent. Conclusion: ChEBI-N is an extended successor to BiNChE for ontology-based enrichment analysis of metabolomics data, offering a hypothesis-generating complement to existing metabolomics analysis pipelines. Availability: ChEBI-N is freely available at chebin.hastingslab.org or as a Python package (pypi.org/project/chebin), with source code at github.com/ontology-tools/chebin, archived at Zenodo (doi:10.5281/zenodo.23264219) and Software Heritage (swh:1:rev:133a41792704eb7f1db746f36a5ae97e9247b2b7).

bioinformatics↗

Integrating Multisource Target Evidence with Machine-Learning Potency Prediction for Alzheimer's Disease Drug Discovery

Alzheimer's disease (AD) target evidence is distributed across biological, chemical, structural, regulatory, and trial-registry sources, complicating reproducible target evaluation and modeling. We developed a traceable data-to-model platform that integrates AGORA-centered evidence through Target Explorer, Drug-Target Lookup, and Model Portfolio workspaces. The resource contains 967 targets, 452,249 compounds, and 1,430,260 measurements. On a curated PIK3CA dataset, target-specific fine-tuning of the Boltz-2 affinity head increased Pearson r from 0.248 to 0.560 and reduced mean absolute error from 0.900 to 0.706 on 469 held-out compounds. Separately, we screened 42 regression models over 50 random splits for ten moderate-sized target datasets; a random forest model for XDH achieved the highest mean R^2 (0.815). The platform connects curated evidence, model-ready datasets, reproducible evaluation, and public results while clearly separating contextual evidence from therapeutic claims and random-split performance from generalization to unseen chemical scaffolds.

bioinformatics↗